These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37544877)

  • 61. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) with concomitant acute chikungunya virus infection: possible role of new viral trigger.
    Sil A; Bhattacharjee MS; Chandra A; Pramanik JD
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34642219
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
    Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
    Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
    J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antipsychotics Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Literature Review and a Report of a Suspected Case Related to Chlorpromazine.
    Ghozlane L; Asma J; Ahmed Z; Ons C; Sarrah K; Riadh D; Sihem EA
    Curr Drug Saf; 2023; 18(4):571-575. PubMed ID: 35658883
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A case of DRESS (drug reaction with eosinophilia and systemic symptoms) under treatment with eslicarbazepine.
    Willikens S; Wolking S
    Seizure; 2019 Nov; 72():11-12. PubMed ID: 31541846
    [No Abstract]   [Full Text] [Related]  

  • 66. Furosemide-Associated Drug Reaction With Eosinophilia and Systemic Symptoms.
    Kumar A; Devi A; Kumar M
    Am J Ther; 2022 Nov-Dec 01; 29(6):e735-e737. PubMed ID: 33021525
    [No Abstract]   [Full Text] [Related]  

  • 67. Valacyclovir-induced drug reaction with eosinophilia and systemic symptoms.
    Kitayama S; Makino T; Kataoka K; Mori S; Furukawa F; Torai R; Mizawa M; Shimizu T
    Eur J Dermatol; 2022 Jul; 32(4):538-539. PubMed ID: 36301753
    [No Abstract]   [Full Text] [Related]  

  • 68. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.
    Cho YT; Yang CW; Chu CY
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598363
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug reaction with eosinophilia and systemic symptoms syndrome induced by apixaban.
    Menteşoğlu D; Doğan Günaydın S; Ersoy-Evans S
    Dermatol Ther; 2020 Jul; 33(4):e13719. PubMed ID: 32472629
    [No Abstract]   [Full Text] [Related]  

  • 70. Sequential screening of biomarkers in a case of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms occurring with virus reactivation and autoimmune disease.
    Lee E; Lee S; Tashiro Y; Ogihara M; Watanabe H; Ishibashi S; Nagata S; Miyo K; Ohara M; Otsuki T; Sueki H
    J Dermatol; 2022 Jul; 49(7):e221-e223. PubMed ID: 35243680
    [No Abstract]   [Full Text] [Related]  

  • 71. Drug reaction with eosinophilia and systemic symptoms syndrome associated with osimertinib.
    Ferreira SC; Gaspar C; Dionísio J; Moura C; Almodovar T
    Pulmonology; 2021; 27(3):266-267. PubMed ID: 32782225
    [No Abstract]   [Full Text] [Related]  

  • 72. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
    Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
    Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome?
    Güner MD; Tuncbilek S; Akan B; Caliskan-Kartal A
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26021379
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug reaction with eosinophilia and systemic symptoms within 1 week of exposure to the drug.
    Sasidharanpillai S; Ajithkumar K; Khader A; Reena Mariyath OK
    J Am Acad Dermatol; 2020 Jul; 83(1):e17-e18. PubMed ID: 32179083
    [No Abstract]   [Full Text] [Related]  

  • 75. Statin-induced drug reaction with eosinophilia and systemic symptoms.
    Khan N; Bernstein D
    Ann Allergy Asthma Immunol; 2022 Feb; 128(2):226-228. PubMed ID: 34732377
    [No Abstract]   [Full Text] [Related]  

  • 76. Skin reaction with Eosinophilia and Systemic Symptoms after lenalidomide in peritoneal Dialysis.
    Cazzato S; Fontana F; Maccaferri M; Leonelli M; Ascione E; Magistroni R; Alfano G
    G Ital Nefrol; 2022 Oct; 39(5):. PubMed ID: 36563074
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug reaction with eosinophilia and systemic symptoms (DRESS) induced by phenytoin re-exposure: case report and systematic review.
    Morán-Mariños C; Alva-Diaz C; De la Cruz Ramirez W; Quincho-Lopez A; Mori N; Pacheco-Mendoza J; Romero-Sánchez R
    Acta Clin Belg; 2022 Feb; 77(1):177-185. PubMed ID: 32469684
    [No Abstract]   [Full Text] [Related]  

  • 78. Periorbital swelling with crusted lesions: Drug reaction with eosinophilia and systemic symptoms.
    Matsuura H; Kiura Y; Kishida M
    Am J Med Sci; 2022 Nov; 364(5):e8-e9. PubMed ID: 35718126
    [No Abstract]   [Full Text] [Related]  

  • 79. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in two young children: the importance of an early diagnosis.
    Castellazzi ML; Esposito S; Claut LE; Daccò V; Colombo C
    Ital J Pediatr; 2018 Aug; 44(1):93. PubMed ID: 30111350
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
    Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
    Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.